Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation
Philippe Gosse(Inserm), Michel Azizi(Inserm), Marc Sapoval(Délégation Paris 5), Émile Ferrari(Johnson University), Jean Ribstein, Caroline Dourmap(Délégation Paris 5), Pierre‐Yves Courand(Université Claude Bernard Lyon 1), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Jean‐Jacques Mourad(Institut Hospitalier Franco Britannique), Matthieu Monge(Délégation Paris 5), B Chamontin(Inserm), Xavier Girerd(Sorbonne Université), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Pascal Delsart(Inserm), Gilles Châtellier(Hôpital Saint Joseph), Héléna Pereira(Inserm), Pierre Lantelme(Inserm), Patrick Rossignol(Inserm), Claire Mounier‐Véhier(Inserm), Thierry Denolle(Inserm), D Herpin(Centre Jean Bernard), Guillaume Bobrie(Assistance Publique – Hôpitaux de Paris), Antoine Crémer(Hôpital Saint-André), Olivier Ormezzano(Inserm), B. Vaı̈sse(Inserm)
Cited by 43
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k